Background
ChemicalBook > CAS DataBase List > 5-(TETRADECYLOXY)-2-FUROIC ACID

5-(TETRADECYLOXY)-2-FUROIC ACID

Background
Product Name
5-(TETRADECYLOXY)-2-FUROIC ACID
CAS No.
54857-86-2
Chemical Name
5-(TETRADECYLOXY)-2-FUROIC ACID
Synonyms
TOFA;mdl14514;RMI-14514;TOFA (RMI14514;RMI14514; MDL14514;TOFA, 10 mM in DMSO;TOFA (RMI14514:MDL14514);5-tetradecyloxy-2-furonicacid;5-(TETRADECYLOXY)-2-FUROIC ACID;5-(TETRADECYLOXY)-2-FUROIC TOFA
CBNumber
CB4759746
Molecular Formula
C19H32O4
Formula Weight
324.45
MOL File
54857-86-2.mol
More
Less

5-(TETRADECYLOXY)-2-FUROIC ACID Property

Melting point:
112-115 °C
Boiling point:
441.7±25.0 °C(Predicted)
Density 
1.003±0.06 g/cm3(Predicted)
storage temp. 
-20°C
solubility 
DMSO: 2.5 mg/mL
form 
solid
pka
3.55±0.10(Predicted)
color 
white to beige
Stability:
Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 1 month.
InChI
1S/C19H32O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-16-22-18-15-14-17(23-18)19(20)21/h14-15H,2-13,16H2,1H3,(H,20,21)
InChIKey
CZRCFAOMWRAFIC-UHFFFAOYSA-N
SMILES
CCCCCCCCCCCCCCOc1ccc(o1)C(O)=O
More
Less

Safety

WGK Germany 
2
RTECS 
LU0288000
HS Code 
29321900
Storage Class
11 - Combustible Solids
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
T6575
Product name
TOFA
Purity
≥98% (HPLC)
Packaging
5mg
Price
$240
Updated
2025/07/31
Sigma-Aldrich
Product number
613450
Product name
TOFA
Packaging
5mg
Price
$401
Updated
2025/07/31
Cayman Chemical
Product number
10005263
Product name
TOFA
Purity
≥98%
Packaging
5mg
Price
$37
Updated
2024/03/01
Cayman Chemical
Product number
10005263
Product name
TOFA
Purity
≥98%
Packaging
10mg
Price
$62
Updated
2024/03/01
Sigma-Aldrich
Product number
T6575
Product name
TOFA
Purity
≥98% (HPLC)
Packaging
25mg
Price
$949
Updated
2025/07/31
More
Less

5-(TETRADECYLOXY)-2-FUROIC ACID Chemical Properties,Usage,Production

Description

TOFA (54857-86-2) interferes with fatty acid synthase via inhibition of acetyl Co-A carboxylase (ACC1).1 Induces apoptosis in a variety of tumor cell lines.2,3 Stimulates neurite outgrowth and neuronal differentiation in rat pheochromocytoma cells.4 TOFA impairs glucose-stimulated insulin secretion after chronic treatment.5

Uses

TOFA has been used as a lipid biosynthesis inhibitor in mesenchymal stromal cells (MSCs), human pluripotent stem cells., an acetyl-CoA carboxylase 1 inhibitor in murine adipocyte cell lines., a lipolysis inhibitor in cancer stem cells (CSCs).

Definition

ChEBI: A member of the class of furans that is 2-furoic acid in which the hydrogen at position 5 is replaced by a tetradecyloxy group.

Biochem/physiol Actions

5-(Tetradecyloxy)-2-furoic acid (TOFA) elicits hypolipidemic?functionality by favoring fatty acid breakdown and at the same time preventing biosynthesis. It induces apoptosis in pancreatic cancer cells and favors tumor suppression.

in vivo

TOFA inhibits COC1/DDP cell growth in ovarian tumor mouse xenografts. The tumor growth rate is signifi cantly inhibited by TOFA compared with the DMSO treated control mice (1649±356.3 vs. 5128±390.4 mm3. No toxicity is observed in the heart, liver, spleen, lung, kidney and intestinal tissues. By inhibiting ACC, TOFA may be a promising small molecule agent for ovarian cancer therapy[2].

Background

The small-molecule TOFA is an allosteric inhibitor of acetyl-CoA carboxylase-α, which catalyzes carboxylation of acetyl-CoA to malonyl-CoA in cells. It is the key enzyme in the biosynthesis and oxidation of fatty acids. Conversion of TOFA to an acetyl-CoA analog that cannot be further metabolized to malonyl-CoA creates an allosteric inhibitor of ACC. Because many cancer cells require fatty acids for high metabolic needs and rapid proliferation, the reduction of ACC activity is a common target in limiting cancer cell growth. TOFA treatment of lung cancer and colon carcinoma cells blocked fatty acid synthesis, and increased fatty acid oxidation and ketogenesis, inducing apoptosis and cell death. Exposure of human pancreatic cancer cells to TOFA resulted in fatty acid depletion, increased caspase-3 activity, and induced cell death. TOFA treatment of human renal cell carcinoma inhibited cell growth and arrested cell cycle at G2/M phase, leading to apoptosis.

References

References/Citations:
(1)Halvorson et al. (1984), Inhibition of fatty acid synthesis in isolated adipocytes by 5-tetradecyloxy)-2-furoic acid; Lipids, 19 851
(2) Guseva et al. (2011), TOFA (5-tetradecyl-oxy-2-furoic acid) reduces fatty acid synthesis, inhibits expression of AR, neuropilin-1 and Mcl-1 and kills prostate cancer cells independent of p53 status; Cancer Biol. Ther., 12 80
(3) Zhou et al. (2003), Fatty acid synthesis inhibition triggers apoptosis during S phase in human cancer cells; Cancer Res., 63 7330
(4) Schmidt et al. (1999), Transcription control and neuronal differentiation by agents that activate the LXR nuclear receptor family; Mol. Cell. Endocrinol., 155 51
(5) Ronnebaum et al. (2008), Chronic suppression of acetyl-CoA carboxylase 1 in beta-cells impairs insulin secretion via inhibition of glucose rather than lipid metabolism; J. Biol. Chem., 283 14248

5-(TETRADECYLOXY)-2-FUROIC ACID Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

5-(TETRADECYLOXY)-2-FUROIC ACID Suppliers

NewCan Biotech Limited
Tel
+86-0571-86912261 +86-15658003402
Fax
311113
Email
sales@newcanbio.com
Country
China
ProdList
1475
Advantage
58
Shanghai Boyle Chemical Co., Ltd.
Tel
021-50182298 021-50180596
Fax
+86-21-57758967
Email
sales@boylechem.com
Country
China
ProdList
2208
Advantage
55
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
Tel
17702719238 18971495150;
Email
sales@sun-shinechem.com
Country
China
ProdList
1112
Advantage
64
Guangzhou Isun Pharmaceutical Co., Ltd
Tel
020-39119399 18927568969
Fax
020-39119999
Email
isunpharm@qq.com
Country
China
ProdList
4720
Advantage
55
Bide Pharmatech Ltd.
Tel
400-400-164-7117 18317119277
Fax
+86-21-61629029
Email
product02@bidepharm.com
Country
China
ProdList
40000
Advantage
60
Shanghai Macklin Biochemical Co.,Ltd.
Tel
15221275939
Fax
021-50706099
Email
shenlinxing@macklin.cn
Country
China
ProdList
15872
Advantage
55
Sigma-Aldrich
Tel
021-61415566 800-8193336
Email
orderCN@merckgroup.com
Country
China
ProdList
51395
Advantage
80
Shanghai Lollane Biological Technology Co.,Ltd.
Tel
021-52996696,15000506266 15000506266
Fax
+86-21-52996696
Country
China
ProdList
4796
Advantage
55
Shanghai Synchem Pharma Co., ltd
Tel
21-619849051-1 18521059765
Email
synchempharma@aliyun.com
Country
China
ProdList
5307
Advantage
55
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Fax
021-65675885
Email
info@efebio.com
Country
China
ProdList
9803
Advantage
58
More
Less

View Lastest Price from 5-(TETRADECYLOXY)-2-FUROIC ACID manufacturers

Career Henan Chemical Co
Product
5-(TETRADECYLOXY)-2-FUROIC ACID 54857-86-2
Price
US $6.60/KG
Min. Order
1KG
Purity
97%-99%
Supply Ability
1kg -1000kg
Release date
2020-01-02

54857-86-2, 5-(TETRADECYLOXY)-2-FUROIC ACIDRelated Search:


  • TOFA
  • 5-(tetradecyloxy)-2-furancarboxylicaci
  • 5-tetradecyloxy-2-furonicacid
  • mdl14514
  • RMI-14514
  • TOFA (5-(Tetradecyloxy)-2-furoic acid)
  • 5-(TETRADECYLOXY)-2-FURANCARBOXYLIC ACID
  • 5-(TETRADECYLOXY)-2-FUROIC ACID
  • 2-Furancarboxylic acid,5-(tetradecyloxy)-
  • TOFA (RMI14514
  • TOFA (RMI14514:MDL14514)
  • 5-(TETRADECYLOXY)-2-FUROIC TOFA
  • TOFA - CAS 54857-86-2 - Calbiochem
  • RMI14514; MDL14514
  • inhibit,RMI 14514,Acetyl-CoA Carboxylase,ACC, Acetyl Coenzyme A Carboxylase,RMI-14514,TOFA,MDL 14514,MDL-14514,Inhibitor
  • TOFA (5-(tetradecyloxy)-2-furoic acid), acetyl-CoA carboxylase inhibitor.
  • TOFA, 10 mM in DMSO
  • TOFA (5-(Tetradecyloxy)-2-furoic acid) ,S6690
  • 54857-86-2
  • A to C
  • Biochemicals and Reagents
  • BioChemical
  • Enzyme Inhibitors
  • Enzyme Inhibitors by Enzyme
  • Enzymes, Inhibitors, and Substrates
  • Acetyl CoA-Carboxylase